Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MYL9 |
| Upstream (Parents) |
|---|
| (<<) ISLR → MYL9 |
| (<<) LOXL1 → MYL9 |
| (<<) TAGLN → MYL9 |
| (<<) ACTA2 → MYL9 |
| Downstream (Children) |
|---|
| MYL9 → ARHGEF38 (>>) |
| MYL9 → MXRA7 (>>) |
| MYL9 → NES (>>) |
| MYL9 → STON1 (>>) |
| MYL9 → FLNA (>>) |
| MYL9 → PLN (>>) |
| MYL9 → ELN (>>) |
| MYL9 → SLC24A3 (>>) |
| MYL9 → HOPX (>>) |
| MYL9 → SYDE1 (>>) |
| MYL9 → TAGLN (>>) |
| MYL9 → FAM49B (>>) |
| MYL9 → CRYAB (>>) |
| MYL9 → ACTG2 (>>) |
| MYL9 → HOMER3 (>>) |
| MYL9 → TGFB1I1 (>>) |
